Skip to Main Content

Paper Details

Genetic events associated with venetoclax resistance in CLL identified by whole-exome sequencing of patient samples.
Blood
3
2023
8p, B-cell receptor, BCL2, BCL2-G101V mutation, BCR, CLL, CLL cells, MAPK, MAPK genes, MCL1, MCL1 gene, NF-B gene, NF-B gene sets, Progression samples, bulk RNA, cells, gain (1q21, loss, loss(8p), pERK, patient, patients, surface immunoglobulin M, tumor, variant allele, venetoclax
Author NameAffiliation
Svitlana TyekuchevaDana-Farber Cancer Institute, Harvard TH Chan School of Public Health
Kahn Rhrissorrakrai
Ignaty LeshchinerBroad Institute of MIT and Harvard
Gad GetzBroad Institute of MIT and Harvard
Gad GetzCancer Center, Massachusetts General Hospital
Gad GetzMassachusetts General Hospital
Gad GetzBroad Institute of MIT and Harvard
Gad GetzCancer Center, Massachusetts General Hospital
Gad GetzMassachusetts General Hospital
  • 1 - 9

Datasets

Release 1.2